Avenciguat: a novel soluble guanylate cyclase activator that affects multiple cell types to inhibit IFN-1 signalling and fibrosis
阿文西呱:一种新型可溶性鸟苷酸环化酶激活剂,可影响多种细胞类型,抑制IFN-1信号传导和纤维化。
期刊:Rheumatology
影响因子:4.4
doi:10.1093/rheumatology/keaf109
Kaufman, Julia; Nabozny, Gerald; Tran-Manh, Cuong; Liebel, Christoph; Zhou, Xiang; Daley, Lee-Anne; Wang, Chao-Ting; Ebenezer, David L; Delic, Denis; Wohnhaas, Christian T; Trinh-Minh, Thuong; Distler, Jörg H W